Skip to main content
SpringerLink
Log in

Ersttrimesterscreening

  • Chapter
  • First Online:
Ultraschalldiagnostik in Geburtshilfe und Gynäkologie

  • 5321 Accesses

Zusammenfassung

Ein Screeningtest muss grundsätzlich von einem diagnostischen Test unterschieden werden. Mithilfe eines diagnostischen Tests, wie zum Beispiel der Amniozentese oder der Chorionzottenbiopsie, wird eine fetale Chromosomenstörung, wie die Trisomie 21, 18 oder 13 in aller Regel eindeutig erkannt. Diese Tests tragen aber ein Fehlgeburtsrisiko von etwa 0,5 % und sind kostenintensiv (Tabor u. Alfirevic 2010). Demgegenüber stehen Screeningtests, wie das Ersttrimesterscreening, die einerseits nicht mit einem Fehlgeburtsrisiko vergesellschaftet und andererseits kostengünstiger sind. Durch sie wird aber nur das Risiko für das Vorliegen einer entsprechenden Erkrankung ermittelt.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 199.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Literatur

  • Abele H, Wagner N, Hoopmann M, Grischke EM, Wallwiener D, Kagan KO (2010) Effect of deviation from the mid-sagittal plane on the measurement of fetal nuchal translucency. Ultrasound Obstet Gynecol 35(5):525–529

    Article  CAS  PubMed  Google Scholar 

  • Akolekar R, Syngelaki A, Sarquis R, Zvanca M, Nicolaides KH (2011) Prediction of early, intermediate and late pre-eclampsia from maternal factors, biophysical and biochemical markers at 11–13 weeks. Prenat Diagn 31(1):66–74

    Article  PubMed  Google Scholar 

  • Ashoor G, Syngelaki A, Poon LCY, Rezende JC, Nicolaides KH (2013) Fetal fraction in maternal plasma cell-free DNA at 11–13 weeks’ gestation: relation to maternal and fetal characteristics. Ultrasound Obstet Gynecol 41(1):26–32

    Article  CAS  PubMed  Google Scholar 

  • Atzei A, Gajewska K, Huggon IC, Allan L, Nicolaides KH (2005) Relationship between nuchal translucency thickness and prevalence of major cardiac defects in fetuses with normal karyotype. Ultrasound Obstet Gynecol 26(2):154–157

    Article  CAS  PubMed  Google Scholar 

  • Benn P, Cuckle H, Pergament E (2013) Non-invasive prenatal testing for aneuploidy: current status and future prospects. Ultrasound Obstet Gynecol 42(1):15–33

    Article  CAS  PubMed  Google Scholar 

  • Beta J, Akolekar R, Ventura W, Syngelaki A, Nicolaides KH (2011) Prediction of spontaneous preterm delivery from maternal factors, obstetric history and placental perfusion and function at 11–13 weeks. Prenat Diagn 31(1):75–83

    Article  PubMed  Google Scholar 

  • Bilardo CM, Muller MA, Pajkrt E, Clur SA, van Zalen MM, Bijlsma EK (2007) Increased nuchal translucency thickness and normal karyotype: time for parental reassurance. Ultrasound Obstet Gynecol 30(1):11–18

    Article  CAS  PubMed  Google Scholar 

  • Bilardo CM, Timmerman E, Pajkrt E, van Maarle M (2010) Increased nuchal translucency in euploid fetuses – what should we be telling the parents? Prenat Diagn 30(2):93–102

    Article  CAS  PubMed  Google Scholar 

  • Borenstein M, Persico N, Kagan KO, Gazzoni A, Nicolaides KH (2008) Frontomaxillary facial angle in screening for trisomy 21 at 11 + 0 to 13 + 6 weeks. Ultrasound Obstet Gynecol 32(1):5–11

    Article  CAS  PubMed  Google Scholar 

  • Bujold E, Roberge S, Lacasse Y, Bureau M, Audibert F, Marcoux S, Forest JC, Giguère Y (2010) Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis. Obstet Gynecol 116(2 Pt 1):402–414

    Article  PubMed  Google Scholar 

  • Cicero S, Avgidou K, Rembouskos G, Kagan KO, Nicolaides KH (2006) Nasal bone in first–trimester screening for trisomy 21. Am J Obstet Gynecol 195(1):109–114

    Article  CAS  PubMed  Google Scholar 

  • Cicero S, Dezerega V, Andrade E, Scheier M, Nicolaides KH (2003) Learning curve for sonographic examination of the fetal nasal bone at 11–14 weeks. Ultrasound Obstet Gynecol 22(2):135–137

    Article  CAS  PubMed  Google Scholar 

  • Cuckle H, Benn P, Wright D (2005) Down syndrome screening in the first and/or second trimester: model predicted performance using meta-analysis parameters. Semin Perinatol 29(4):252–257

    Article  PubMed  Google Scholar 

  • Cuckle HS (2011) Screening for pre-eclampsia – lessons from aneuploidy screening. Placenta 32(Suppl):S42–S48

    Article  PubMed  Google Scholar 

  • Cuckle HS, Wald NJ, Thompson SG (1987) Estimating a woman’s risk of having a pregnancy associated with Down’s syndrome using her age and serum alpha-fetoprotein level. Br J Obstet Gynaecol 94(5):387–402

    Article  CAS  PubMed  Google Scholar 

  • Dan S, Wang W, Ren J, Xu Z, Hu H, Li Y et al (2012) Clinical application of massively parallel sequencing-based prenatal noninvasive fetal trisomy test for trisomies 21 and 18 in 11,105 pregnancies with mixed risk factors. Prenat Diagn 32(13):1225–1232

    Article  PubMed  Google Scholar 

  • De Souza E, Halliday J, Chan A, Bower C, Morris JK (2009) Recurrence risks for trisomies 13, 18 and 21. Am J Med Genet A 149(12):2716–2722

    Article  Google Scholar 

  • Ekelund CK, Jorgensen FS, Petersen OB, Sundberg K, Tabor A (2008) Impact of a new national screening policy for Down’s syndrome in Denmark: population based cohort study. BMJ 337:a2547

    Article  PubMed  PubMed Central  Google Scholar 

  • Fan HC, Gu W, Wang J, Blumenfeld YJ, El-Sayed YY, Quake SR (2012) Non-invasive prenatal measurement of the fetal genome. Nature 487(7407):320–324

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ferreira AF, Rezende JC, Vaikousi E, Akolekar R, Nicolaides KH (2011) Maternal serum visfatin at 11–13 weeks of gestation in gestational diabetes mellitus. Clin Chem 57(4):609–613

    Article  CAS  PubMed  Google Scholar 

  • Flenady V, Koopmans L, Middleton P, Frøen JF, Smith GC, Gibbons K, Coory M, Gordon A, Ellwood D, McIntyre HD, Fretts R, Ezzati M (2011) Major risk factors for stillbirth in high-income countries: a systematic review and meta-analysis. Lancet 377(9774):1331–1340

    Article  PubMed  Google Scholar 

  • Fuchs IB, Muller H, Abdul-Khaliq H, Harder T, Dudenhausen JW, Henrich W (2007) Immediate and long-term outcomes in children with prenatal diagnosis of selected isolated congenital heart defects. Ultrasound Obstet Gynecol 29(1):38–43

    Article  CAS  PubMed  Google Scholar 

  • Greco E, Lange A, Ushakov F, Calvo JR, Nicolaides KH (2011) Prediction of spontaneous preterm delivery from endocervical length at 11 to 13 weeks. Prenat Diagn 31(1):84–89

    Article  PubMed  Google Scholar 

  • Hoopmann M, Abele H, Wagner N, Wallwiener D, Kagan KO (2010) Performance of 36 Different Weight Estimation Formulae in Fetuses with Macrosomia. Fetal Diagn Ther 27(4):204–213

    Article  PubMed  Google Scholar 

  • Hyett J, Perdu M, Sharland G, Snijders R, Nicolaides KH (1999) Using fetal nuchal translucency to screen for major congenital cardiac defects at 10–14 weeks of gestation: population based cohort study. BMJ 318(7176):81–85

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kagan K, Hoopmann M, Kozlowski P (2012) Assessment of Foetal DNA in Maternal Blood – A Useful Tool in the Hands of Prenatal Specialists. Geburtsh Frauenheilk 72(11):998–1003

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kagan KO, Eiben B, Kozlowski P (2013) Kombiniertes Ersttrimesterscreening und zell-freie fetale DNA – „Next generation screening“. Ultraschall in Med (in press)

    Google Scholar 

  • Kagan KO, Anderson JM, Anwandter G, Neksasova K, Nicolaides KH (2008) Screening for triploidy by the risk algorithms for trisomies 21 18 and 13 at 11 weeks to 13 weeks and 6 days of gestation. Prenat Diagn 28(13):1209–1213

    Article  PubMed  Google Scholar 

  • Kagan KO, Avgidou K, Molina FS, Gajewska K, Nicolaides KH (2006) Relation between increased fetal nuchal translucency, thickness and chromosomal defects. Obstet Gynecol 107(1):6–10

    Article  PubMed  Google Scholar 

  • Kagan KO, Cicero S, Staboulidou I, Wright D, Nicolaides KH (2009) Fetal nasal bone in screening for trisomies 21, 18 and 13 and Turner syndrome at 11–13 weeks of gestation. Ultrasound Obstet Gynecol 33(3):259–264

    Article  CAS  PubMed  Google Scholar 

  • Kagan KO, Etchegaray A, Zhou Y, Wright D, Nicolaides KH (2009) Prospective validation of first-trimester combined screening for trisomy 21. Ultrasound Obstet Gynecol 34(1):14–18

    Article  CAS  PubMed  Google Scholar 

  • Kagan KO, Etchegaray A, Zhou Y, Wright D, Nicolaides KH (2009) Prospective validation of first-trimester combined screening for trisomy 21. Ultrasound Obstet Gynecol 34(1):14–18

    Article  CAS  PubMed  Google Scholar 

  • Kagan KO, Gazzoni A, Sepulveda-Gonzalez G, Sotiriadis A, Nicolaides KH (2007) Discordance in nuchal translucency, thickness in the prediction of severe twin-to-twin transfusion syndrome. Ultrasound Obstet Gynecol 29(5):527–532

    Article  CAS  PubMed  Google Scholar 

  • Kagan KO, Staboulidou I, Cruz J, Wright D, Nicolaides KH (2010) Two-stage first-trimester screening for trisomy 21 by ultrasound assessment and biochemical testing. Ultrasound Obstet Gynecol 36(5):542–547

    Article  CAS  PubMed  Google Scholar 

  • Kagan KO, Staboulidou I, Syngelaki A, Cruz J, Nicolaides KH (2010) The 11–13-week scan: diagnosis and outcome of holoprosencephaly exomphalos and megacystis. Ultrasound Obstet Gynecol 36(1):10–14

    Article  CAS  PubMed  Google Scholar 

  • Kagan KO, Valencia C, Livanos P, Wright D, Nicolaides KH (2009) Tricuspid regurgitation in screening for trisomies 21, 18 and 13 and Turner syndrome at 11+0 to 13+6 weeks of gestation. Ultrasound Obstet Gynecol 33(1):18–22

    Article  CAS  PubMed  Google Scholar 

  • Kagan KO, Wright D, Baker A, Sahota D, Nicolaides KH (2008) Screening for trisomy 21 by maternal age fetal nuchal translucency thickness free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A. Ultrasound Obstet Gynecol 31(6):618–624

    Article  CAS  PubMed  Google Scholar 

  • Kagan KO, Wright D, Etchegaray A, Zhou Y, Nicolaides KH (2009) Effect of deviation of nuchal translucency measurements on the performance of screening for trisomy 21. Ultrasound Obstet Gynecol 33(6):657–664

    Article  CAS  PubMed  Google Scholar 

  • Kagan KO, Wright D, Spencer K, Molina FS, Nicolaides KH (2008) First-trimester screening for trisomy 21 by free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A: impact of maternal and pregnancy characteristics. Ultrasound Obstet Gynecol 31(5):493–502

    Article  CAS  PubMed  Google Scholar 

  • Kagan KO, Wright D, Valencia C, Maiz N, Nicolaides KH (2008) Screening for trisomies 21 18 and 13 by maternal age fetal nuchal translucency fetal heart rate free beta-hCG and pregnancy-associated plasma protein-A. Hum Reprod 23(9):1968–1975

    Article  CAS  PubMed  Google Scholar 

  • Karagiannis G, Akolekar R, Sarquis R, Wright D, Nicolaides KH (2011) Prediction of small-for-gestation neonates from biophysical and biochemical markers at 11–13 weeks. Fetal Diagn Ther 29(2):148–154

    Article  PubMed  Google Scholar 

  • Kitzman JO, Snyder MW, Ventura M, Lewis AP, Qiu R, Simmons LE et al (2012) Noninvasive whole-genome sequencing of a human fetus. Sci Transl Med 4(137):137ra76

    Article  PubMed  PubMed Central  Google Scholar 

  • Kuc S, Wortelboer EJ, Koster MP, de Valk HW, Schielen PC, Visser GH (2011) Prediction of macrosomia at birth in type-1 and 2 diabetic pregnancies with biomarkers of early placentation. BJOG 118(6):748–754

    Article  CAS  PubMed  Google Scholar 

  • Liang D, Lv W, Wang H, Xu L, Liu J, Li H et al (2013) Non-invasive prenatal testing of fetal whole chromosome aneuploidy by massively parallel sequencing. Prenat Diagn 33(5):409–415

    Article  CAS  PubMed  Google Scholar 

  • Lo YM, Corbetta N, Chamberlain PF, Redman CW, Sargent IL, Rai V et al (1997) Presence of fetal DNA in maternal plasma and serum. Lancet 350(9076):485–487

    Article  CAS  PubMed  Google Scholar 

  • Madsen HN, Ball S, Wright D, Tørring N, Petersen OB, Nicolaides KH, Spencer K (2011) A reassessment of biochemical marker distributions in trisomy 21-affected and unaffected twin pregnancies in the first trimester. Ultrasound Obstet Gynecol 37(1):38–47

    Article  CAS  PubMed  Google Scholar 

  • Maiz N, Kagan KO, Milovanovic Z, Celik E, Nicolaides KH (2008) Learning curve for Doppler assessment of ductus venosus flow at 11 + 0 to 13 + 6 weeks’ gestation. Ultrasound Obstet Gynecol 31(5):503–506

    Article  CAS  PubMed  Google Scholar 

  • Maiz N, Valencia C, Kagan KO, Wright D, Nicolaides KH (2009) Ductus venosus Doppler in screening for trisomies 21,18 and 13 and Turner syndrome at 11–13 weeks of gestation. Ultrasound Obstet Gynecol 33(5):512–517

    Article  CAS  PubMed  Google Scholar 

  • Malone FD (2005) Nuchal translucency-based Down syndrome screening: barriers to implementation. Semin Perinatol 29(4):272–276

    Article  PubMed  Google Scholar 

  • Matias A, Montenegro N, Loureiro T, Cunha M, Duarte S, Freitas D, Severo M (2010) Screening for twin–twin transfusion syndrome at 11–14 weeks of pregnancy: the key role of ductus venosus blood flow assessment. Ultrasound Obstet Gynecol 35(2):142–148

    Article  CAS  PubMed  Google Scholar 

  • Mazloom AR, Džakula Z, Oeth P, Tynan J, Jensen T, Wang H et al (2013) Noninvasive prenatal detection of sex chromosomal aneuploidies by sequencing circulating cell-free DNA from maternal plasma. Prenat Diagn 33(6):591–597

    Article  CAS  PubMed  Google Scholar 

  • Merz E, Thode C, Alkier A, Eiben B, Hackelöer BJ, Hansmann M, Huesgen G, Kozlowski P, Pruggmaier M, Wellek S (2008) A new approach to calculating the risk of chromosomal abnormalities with first-trimester screening data. Ultraschall in der Medizin 29(6):639–645

    Article  CAS  PubMed  Google Scholar 

  • Molina FS, Avgidou K, Kagan KO, Poggi S, Nicolaides KH (2006) Cystic hygromas nuchal edema and nuchal translucency at 11–14 weeks of gestation. Obstet Gynecol 107(3):678–683

    Article  PubMed  Google Scholar 

  • Nanda S, Savvidou M, Syngelaki A, Akolekar R, Nicolaides KH (2011) Prediction of gestational diabetes mellitus by maternal factors and biomarkers at 11 to 13 weeks. Prenat Diagn 31(2):135–141

    Article  PubMed  Google Scholar 

  • Nicolaides KH (2003) Screening for chromosomal defects. Ultrasound Obstet Gynecol 21(4):313–321

    Article  CAS  PubMed  Google Scholar 

  • Nicolaides KH (2011) A model for a new pyramid of prenatal care based on the 11 to 13 weeks’ assessment. Prenat Diagn 31(1):3–6

    Article  PubMed  Google Scholar 

  • Nicolaides KH, Spencer K, Avgidou K, Faiola S, Falcon O (2005) Multicenter study of first-trimester screening for trisomy 21 in 75 821 pregnancies: results and estimation of the potential impact of individual risk-orientated two-stage first-trimester screening. Ultrasound Obstet Gynecol 25(3):221–226

    Article  CAS  PubMed  Google Scholar 

  • Nicolaides KH, Syngelaki A, Ashoor G, Birdir C, Touzet G (2012) Noninvasive prenatal testing for fetal trisomies in a routinely screened first-trimester population. Am J Obstet Gynecol 207(5):374.e1–374.e6

    Article  Google Scholar 

  • Papatheodorou S, Evangelou E, Makrydimas G, Ioannidis J (2011) First-trimester ductus venosus screening for cardiac defects: a meta-analysis. BJOG: an international journal of obstetrics and gynaecology Jun 14

    Google Scholar 

  • Pereira S, Ganapathy R, Syngelaki A, Maiz N, Nicolaides KH (2011) Contribution of fetal tricuspid regurgitation in first-trimester screening for major cardiac defects. Obstetrics and gynecology 117(6):1384–1391

    Article  PubMed  Google Scholar 

  • Persico N, Moratalla J, Lombardi CM, Zidere V, Allan L, Nicolaides KH (2011) Fetal echocardiography at 11–13 weeks by transabdominal high-frequency ultrasound. Ultrasound Obstet Gynecol 37(3):296–301

    Article  CAS  PubMed  Google Scholar 

  • Plasencia W, Garcia R, Pereira S, Akolekar R, Nicolaides KH (2011) Criteria for Screening and Diagnosis of Gestational Diabetes Mellitus in the First Trimester of Pregnancy. Fetal Diagn Ther Apr 1

    Article  PubMed  Google Scholar 

  • Poon LC, Karagiannis G, Staboulidou I, Shafiei A, Nicolaides KH (2011) Reference range of birth weight with gestation and first-trimester prediction of small-for-gestation neonates. Prenat Diagn 31(1):58–65

    Article  PubMed  Google Scholar 

  • Poon LC, Karagiannis G, Stratieva V, Syngelaki A, Nicolaides KH (2011) First-trimester prediction of macrosomia. Fetal Diagn Ther 29(2):139–147

    Article  PubMed  Google Scholar 

  • Poon LC, v Kametas NA, Pandeva I, Valencia C, Nicolaides KH (2008) Mean arterial pressure at 11 (+0) to 13 (+6) weeks in the prediction of preeclampsia. Hypertension 51(4):1027–1033

    Article  CAS  PubMed  Google Scholar 

  • Scazzocchio E, Figueras F (2011) Contemporary prediction of preeclampsia. Curr Opin Obstet Gynecol 23(2):65–71

    Article  PubMed  Google Scholar 

  • Schulte-Vallentin M, Schindler H (1992) Non-echogenic nuchal oedema as a marker in trisomy 21 screening. Lancet 25(339):8800

    Google Scholar 

  • Senat MV, Frydman R (2007) Increased nuchal translucency with normal karyotype. Gynecol Obstet Fertil 35(6):507–515

    Article  PubMed  Google Scholar 

  • Snijders RJ, Noble P, Sebire N, Souka A, Nicolaides KH (1998) UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10–14 weeks of gestation Fetal Medicine Foundation First Trimester Screening Group. Lancet 352(9125):343–346

    Article  CAS  PubMed  Google Scholar 

  • Snijders RJ, Sebire NJ, Nicolaides KH (1995) Maternal age and gestational age-specific risk for chromosomal defects. Fetal Diagn Ther 10(6):356–367

    Article  CAS  PubMed  Google Scholar 

  • Souka AP, Von Kaisenberg CS, Hyett JA, Sonek JD, Nicolaides KH (2005) Increased nuchal translucency with normal karyotype. Am J Obstet Gynecol 192(4):1005–1021

    Article  PubMed  Google Scholar 

  • Spencer K, Bindra R, Nix AB, Heath V, Nicolaides KH (2003) Delta-NT or NT MoM: which is the most appropriate method for calculating accurate patient-specific risks for trisomy 21 in the first trimester? Ultrasound Obstet Gynecol 22(2):142–148

    Article  CAS  PubMed  Google Scholar 

  • Spencer K, Cowans NJ, Avgidou K, Nicolaides KH (2006) First-trimester ultrasound and biochemical markers of aneuploidy and the prediction of impending fetal death. Ultrasound Obstet Gynecol 28(5):637–643

    Article  CAS  PubMed  Google Scholar 

  • Spencer K, Kagan KO, Nicolaides KH (2008) Screening for trisomy 21 in twin pregnancies in the first trimester: an update of the impact of chorionicity on maternal serum markers. Prenat Diagn 28(1):49–52

    Article  PubMed  Google Scholar 

  • Spencer K, Nicolaides KH (2003) Screening for trisomy 21 in twins using first trimester ultrasound and maternal serum biochemistry in a one-stop clinic: a review of three years experience. BJOG 110(3):276–280

    Article  CAS  PubMed  Google Scholar 

  • Syngelaki A, Chelemen T, Dagklis T, Allan L, Nicolaides KH (2011) Challenges in the diagnosis of fetal non-chromosomal abnormalities at 11–13 weeks. Prenat Diagn 31(1):90–102

    Article  PubMed  Google Scholar 

  • Szabo J, Gellen J (1990) Nuchal fluid accumulation in trisomy-21 detected by vaginosonography in first trimester Lancet Nov 3: 336 (8723): 1133

    Google Scholar 

  • Tabor A, Alfirevic Z (2010) Update on procedure-related risks for prenatal diagnosis techniques. Fetal Diagn Ther 27(1):1–7

    Article  PubMed  Google Scholar 

  • Tabor A, Vestergaard CH, Lidegaard O (2009) Fetal loss rate after chorionic villus sampling and amniocentesis: an 11-year national registry study. Ultrasound Obstet Gynecol 34(1):19–24

    Article  CAS  PubMed  Google Scholar 

  • Tegnander E, Williams W, Johansen OJ, Blaas HG, Eik-Nes SH (2006) Prenatal detection of heart defects in a non-selected population of 30,149 fetuses – detection rates and outcome. Ultrasound Obstet Gynecol 27(3):252–265

    Article  CAS  PubMed  Google Scholar 

  • The Fetal Medicine Foundation. www. fetalmedicine. com, aufgerufen am 212012

    Google Scholar 

  • To MS, Skentou CA, Royston P, Yu CK, Nicolaides KH (2006) Prediction of patient-specific risk of early preterm delivery using maternal history and sonographic measurement of cervical length: a population-based prospective study. Ultrasound Obstet Gynecol 27(4):362–367

    Article  CAS  PubMed  Google Scholar 

  • Wald NJ, Rodeck C, Hackshaw AK, Walters J, Chitty L, Mackinson AM (2003) First and second trimester antenatal screening for Down’s syndrome: the results of the Serum Urine and Ultrasound Screening Study (SURUSS). J Med Screen 10(2):56–104

    CAS  PubMed  Google Scholar 

  • Wright D, Kagan KO, Molina FS, Gazzoni A, Nicolaides KH (2008) A mixture model of nuchal translucency thickness in screening for chromosomal defects. Ultrasound Obstet Gynecol 31(4):376–383

    Article  CAS  PubMed  Google Scholar 

  • Wright D, Spencer K, Kagan KK, Tørring N, Petersen OB, Christou A, Kallikas J, Nicolaides KH (2010) First-trimester combined screening for trisomy 21 at 7–14 weeks’ gestation. Ultrasound Obstet Gynecol 36(4):404–411

    Article  CAS  PubMed  Google Scholar 

  • Wright D, Syngelaki A, Staboulidou I, Cruz Jde J, Nicolaides KH (2011) Screening for trisomies in dichorionic twins by measurement of fetal nuchal translucency thickness according to the mixture model. Prenat Diagn 31(1):16–21

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Frauenklinik, Universitätsklinikum Tübingen, Calwerstraße 7, 72076, Tübingen, Deutschland

    Karl-Oliver Kagan Prof. Dr. med., Harald Abele PD Dr. & Markus Hoopmann PD Dr. med.

Authors
  1. Karl-Oliver Kagan Prof. Dr. med.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Harald Abele PD Dr.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Markus Hoopmann PD Dr. med.
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Frauenheilkunde, Universitätsklinikum Bonn Zentrum für Geburtshilfe und, Bonn, Germany

    Ulrich Gembruch

  2. Klinik für Geburtshilfe und Pränatalmedizin, Universitätsklinikum Hamburg Eppendorf, Hamburg, Germany

    Kurt Hecher

  3. Praxis f. Frauenhlkd. u. Pränataldiag., Salzburg, Austria

    Horst Steiner

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Kagan, KO., Abele, H., Hoopmann, M. (2013). Ersttrimesterscreening. In: Gembruch, U., Hecher, K., Steiner, H. (eds) Ultraschalldiagnostik in Geburtshilfe und Gynäkologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-29633-8_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-29633-8_5

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-29632-1

  • Online ISBN: 978-3-642-29633-8

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation